Viewing data from:

NEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC AND HYDROCORTISONE

ANDA

BACITRACIN ZINC; HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE | A064068 | BAUSCH AND LOMB INC

1 strength0 unique patents0 unique exclusivities

Products (1)

#001 — 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM

0 patents0 exclusivities▴

OINTMENT;OPHTHALMIC | Approved: Oct 30, 1995

No patent or exclusivity listings for this strength.

Change History (2)

Recent changes detected for this application.

MODIFIEDApplicant Full Name7/1/2026

Bausch and Lomb Pharmaceuticals Inc updated its corporate name to Bausch and Lomb Inc for the neomycin/polymyxin B/bacitracin/hydrocortisone combination product (NDA 064068).

Old: BAUSCH AND LOMB PHARMACEUTICALS INC

New: BAUSCH AND LOMB INC

MODIFIEDApplicant7/1/2026

Bausch and Lomb updated its applicant name from "Bausch and Lomb" to "Bausch and Lomb Inc" for the neomycin, polymyxin B, bacitracin, and hydrocortisone combination product (NDA 064068).

Old: BAUSCH AND LOMB

New: BAUSCH AND LOMB INC